[Federal Register Volume 80, Number 173 (Tuesday, September 8, 2015)]
[Notices]
[Page 53888]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-22061]


-----------------------------------------------------------------------

INTERNATIONAL TRADE COMMISSION

[Investigation No. 731-TA-130 (Fourth Review)]


Chloropicrin From China

Determination

    On the basis of the record \1\ developed in the subject five-year 
review, the United States International Trade Commission 
(``Commission'') determines, pursuant to the Tariff Act of 1930, that 
revocation of the antidumping duty order on chloropicrin from China 
would be likely to lead to continuation or recurrence of material 
injury to an industry in the United States within a reasonably 
foreseeable time.
---------------------------------------------------------------------------

    \1\ The record is defined in sec. 207.2(f) of the Commission's 
Rules of Practice and Procedure (19 CFR 207.2(f)).
---------------------------------------------------------------------------

Background

    The Commission, pursuant to section 751(c) of the Tariff Act of 
1930 (19 U.S.C. 1675(c)), instituted this review on April 1, 2015 (80 
FR 17496) and determined on July 6, 2015 that it would conduct an 
expedited review (80 FR 43461, July 22, 2015).
    The Commission made this determination pursuant to section 751(c) 
of the Tariff Act of 1930 (19 U.S.C. 1675(c)). It completed and filed 
its determination in this review on August 20, 2015. The views of the 
Commission are contained in USITC Publication 4561 (August 2015), 
entitled Chloropicrin from China: Investigation No. 731-TA-130 (Fourth 
Review).

    By order of the Commission.
    Issued: September 1, 2015.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2015-22061 Filed 9-4-15; 8:45 am]
 BILLING CODE 7020-02-P